Origination of Macrocyclic Formazan with Macrocyclic Sulfazan and Triazan as Innovated Compounds and Compared Their efficiency Against Breast Cancer: OAJBS Publishers
Origination of Macrocyclic Formazan with Macrocyclic Sulfazan and Triazan as Innovated Compounds and Compared Their efficiency Against Breast Cancer by Nagham Mahmood Aljamali* in Open Access Journal of Biomedical Science (OAJBS)
Macrocyclic
Sulfazan and Macrocyclic Formazan were created and developed globally for the
first time by researcher Dr. Nagham Aljamali in April 2021, while same
researcher created and innovated Sulfazan compounds as the first time in 2019.,
Therefore, these compounds considered one of the developed and modern compounds
which have a lack of references or scarcity of books and researches. Therefore,
the researcher, Dr. Nagham prepared and created a chain of these innovated
compounds and studied by numerous applications, containing biological,
pharmaceutical studies, also as antifungal, antibacterial, anticancer agents,
and here in this research, also cyclic sulfazan and cyclic formazan were
studied a several applications. A numeral of practical spectroscopic studies
has been used to exhibit their chemical structures which provided strong
evidence of their chemical structures through various technical devices like
(FT IR-Spectra, 1H.NMR-Spectra, Mass-Spectra)., Melting points, other studies
represented by evolution them as bio-compounds by scanning them as anticancer
compounds.
https://biomedscis.com/fulltext/origination-of-macrocyclic-formazan-with-macrocyclic-sulfazan-and-triazan-as-innovated-compounds-and-compared.ID.000383.php
To Know More About Open Access Journal of Biomedical Science Please Visit: Biomedscis
Are Click on: https://Biomedscis.Com/
Comments
Post a Comment